Composition
- Active ingredients
- CIMETIDINE 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- CIMETIDINE 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA017920-004 · Discontinued
- CIMETIDINE 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletThis page
- CIMETIDINE 800MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA017920-005 · Discontinued
- CIMETIDINE 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA017920-003 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA017920.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Tagamet
- Active substance
- cimetidine
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Glaxosmithkline
- Status
- Discontinued
- FDA approval
- 16 Aug 1977
- Application
- NDA017920-002